"Nuclear roles for non-lamin intermediate filament proteins," has been published in Current Opinion in Cell Biology.

Jourdan Triebwasser, M.D., medical director of the University of Michigan Health Von Voigtlander Women's Hospital Birth Center and a maternal-fetal medicine specialist with a particular interest in this condition, shares more about detecting and treating the condition, and the importance of multidisciplinary collaboration in maternal-fetal outcomes.

Hannah (Giger Lab) has been awarded an NIH F31.

How two newly approved gene therapies, including novel technology CRISPR, may help kids and adults with inherited blood disorders

Kyle and Kaylee Berner are enjoying making memories with their baby, Bennett, outside hospital walls. Courtesy of the Berners

The W.M. Keck Foundation has awarded $1.3M to Assistant Professor Ryan Baldridge, Biological Chemistry, and Corydon Ford Collegiate Professor Billy Tsai, CDB, to develop a next-generation protein degradation technology to revolutionize antiviral treatments for endoplasmic reticulum (ER) dysfunction.

"Intrahepatic paracrine signaling by cardiotrophin‐like cytokine factor 1 ameliorates diet‐induced NASH in mice," has been published in Hepatology.

6 ways families can make resolutions stick

Jiaqian Li (Hanson Lab) has been awarded a Rackham International Student Fellowship!

Infants with hemophilia A who received monoclonal antibody emicizumab experienced few bleeding events and no serious complications, a study suggests.

Inadequate health coverage is a particular problem for commercially insured children, according to a Michigan Medicine and Columbia study. The research shows that coverage gaps are affecting publicly insured children as well.

Read Cell & Developmental Biology's 2023 annual report.

Pilar Rivero-Rios and Lois Weisman just published a Perspective in Science

New Publication by Seth Teague and LiAng Yao (Heemskerk Lab)